BRAINTREE, Mass., Nov. 7, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that second quarter and first half fiscal year 2017 financial results are available on its Investor relations website.
The Company is posting this press release and additional commentary entitled Comments on 2nd Quarter and First Half Fiscal 2017 Results to its Investor Relations website.
Direct link to Earnings Release FY17 Q2:
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzU2MzQzfENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636132771088636200
Direct link to Comments on 2nd Quarter and 1st Half Fiscal 2017 Results:
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzU2MzQ0fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636132771875970279
As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on November 7, 2016. A live webcast of the call can be accessed on Haemonetics’ investor relations website.
Direct link to Conference Call Webcast: http://edge.media-server.com/m/p/wcn22ipf/lan/en
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
INVESTOR CONTACT:
Gerry Gould, VP-Investor Relations
(781) 356-9402
gerry.gould@haemonetics.com
MEDIA CONTACT:
Sandra Jesse, Executive VP
(781) 356-9253
sandra.jesse@haemonetics.com
Logo - http://photos.prnewswire.com/prnh/20160405/351568LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-2017-earnings-release-available-on-investor-relations-website-300357960.html
SOURCE Haemonetics Corporation
